Leukeran Tablet, Film Coated
Product Images NDC 80725-610

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Leukeran (NDC 80725-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlorambucil Chemical Structure (Leukeran 1)

Chemical structure diagram of chlorambucil, showing the molecular arrangement including a benzene ring, chloroethyl groups, and a carboxylic acid functional group.*

FDA Label Image

Waylis Logo (Leukeran 2)

FDA Label Image

Carton (Leukeran 4)

Packaging label for LEUKERAN (chlorambucil) 2 mg film-coated tablets by Waylis Therapeutics LLC. The label states each tablet contains 2 mg chlorambucil, with 25 tablets per container. It includes storage instructions to refrigerate at 2° to 8°C and a warning about medical supervision and dosage. The product is made in Germany and labeled with NDC 80725-610-25.*

FDA Label Image

Label (Leukeran 5)

LEUKERAN (chlorambucil) 2 mg oral film-coated tablets label from Waylis Therapeutics LLC. The label indicates 25 tablets per container, storage instructions between 2° to 8°C, and a barcode with product NDC 80725-610-25. It includes a warning about medical supervision and proper dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.